MIMS July prescribing update
Mifepristone Linepharma (mifepristone) contains a synthetic steroid with an antiprogestational action as a result of competition with progesterone at the progesterone receptors.
Oral administration was shown to inhibit the action of endogenous or exogenous progesterone in multiple species (rat, mouse, rabbit, dog and monkey).
This action is manifested in the form of pregnancy termination.
It is indicated in females of childbearing age for